Poly adenosine diphosphate-ribose polymerase (PARP) inhibitors, a class of targeted anticancer therapies, prevent genetic ...

A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study from researchers in the Perelman School of Medicine at the ...

Olive-derived drugs could eventually find a place in your medicine cabinet as HonorHealth researchers explore their potential ...

Cancer is a major global cause of death, resulting in millions of new cases being diagnosed every year. Chemotherapy, radiotherapy, and surgery have led to considerable advancements in patient ...

Researchers have identified a previously unknown bacterial protein, the structure of which is being used in the design of protein nanoparticles for the targeted delivery of anticancer drugs to tumors.

BRCA1 and BRCA2 genes play a crucial role in repairing damaged DNA. Mutations in BRCA1 and BRCA2 substantially increase the likelihood of breast and ovarian cancer, respectively. This new research ...

"Among all former studies on this plant, the most promising activities are found to be its anticancer, antiparasitic and insecticidal activity," researchers noted in a 2015 review paper in the ...

Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments.

These cancers are, however, quite sensitive to anticancer drugs such as poly (ADP-ribose) polymerase inhibitors (PARPi). When successful, these cancer treatments cause enough DNA damage to trigger ...

The combined use of two well-known active substances can fight leukemic cells and limit their spread. This is the result of a ...

(PDCs) demonstrate tumor-selective delivery and potent anticancer activityPreclinical data show robust efficacy ...